Publications & Documents

  • 28-October-2013


    Policies for Bioplastics in the Context of a Bioeconomy

    This paper explores the development of the bioplastics sector and its role in national bioeconomy strategies. It finds that bioplastics are at a disadvantage compared to some other biobased products, notably biofuels, that often benefit from preferential treatment. It also notes that greater efforts are needed at the international level as regards standards to avoid creating barriers to international trade in biobased products.

    Related Documents
  • 22-October-2013


    Managing Hospital Volumes: Germany and Experiences from OECD Countries

    To help inform the Conference on Managing Hospital Volumes, co-organised by the German Federal Ministry of Health and the OECD, and held on the 11th April 2013 in Berlin, the OECD Secretariat produced a paper to provide an international perspective on Germany’s situation and the current policy debate.

  • 4-October-2013


    ICTs and the Health Sector: Towards Smarter Health and Wellness Models

    The future sustainability of health systems will depend on how well governments are able to anticipate and respond to efficiency and quality of care challenges. Bold action is required, as well as willingness to test innovative care delivery approaches. This book examines the whole new world of possibilities in using mobiles and the Internet to address healthcare challenges.

  • 30-September-2013


    Tackling Portugal’s Health Challenges and Promoting Well Being

    In Portugal, health spending has been reduced from 10.8% of GDP in 2009 to 10.2% now. This has been achieved by rationalising spending on pharmaceuticals, promoting the use of generic drugs, moderating salaries; cutting the fees paid to hospitals, and increasing user charges, while still protecting those in most need, said OECD Secretary-General.

    Related Documents
  • 23-September-2013


    Assessing the risk of chemicals to children’s health: an OECD-wide survey

    This document outlines the methodologies and tools currently used to assess the risk of chemicals to children’s health and also identifies possible needs for additional guidance or tools based on the results of an on-line survey conducted in November 2011. The following areas of risk assessment are covered: definitions, hazard and exposure assessment, risk characterisation, cohort studies and combined exposure to multiple chemicals.

    Related Documents
  • 12-September-2013

    English, PDF, 108kb

    The future of public health: policy decisions today for tomorrow’s populations - Speech by Yves Leterme at EPHA

    The future of public health: policy decisions today for tomorrow’s populations. Our health, our economy, our society, our future: a Brave New World. Remarks by Yves Leterme, Deputy Secretary-General, OECD. Brussels, Belgium, September 4th 2013.

    Related Documents
  • 10-September-2013

    English, PDF, 1,992kb

    Report of the International Symposium on Assessing the Economic Impact of Nanotechnology

    Governments have a fiscal and social responsibility to ensure that limited research and development resources are used wisely and cost-effectively in support of social, economic, and scientific aspirations. Countries that wish to promote the continued responsible development of nanotechnology will, however, need quantitative data on the economic impact of nanotechnology to guide further investment and policy decisions.

    Related Documents
  • 4-September-2013


    Marine Biotechnology: Enabling Solutions for Ocean Productivity and Sustainability

    This book discusses scientific and technological tools at the centre of a renewed interest in marine biotechnology that is contributing to a new bioeconomy sector in many countries and offering potential new solutions to global challenges.

    Related Documents
  • 2-August-2013


    Public Health in an Age of Genomics

    This report presents the findings of a research project to investigate the drivers and criteria shaping the application of genomic biotechnology to health in different national settings, and the barriers to implementation nationally and internationally. Findings are based on case studies on Finland, Israel, Luxembourg, Mexico, the United Kingdom, China and South Africa.

    Related Documents
  • 11-July-2013

    English, PDF, 1,115kb

    Expenditure on Prevention Activities under SHA 2011: Supplementary Guidance

    Experience from the substantial health gains of the 20th century suggests that spending on prevention could be an important factor. Therefore, gathering data on such spending that are consistent and comparable, both over time and across countries, is potentially very useful. This paper aims to help clarify what should be included as spending on prevention under SHA 2011 to facilitate accurate comparisons.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 > >>